Belatacept for Maintenance Immunosuppression in Lung Transplantation

• Hauptverfasser: Christine Hui PharmD (Verfasst von), Ryan Kern MD (Verfasst von), David Wojciechowski DO (Verfasst von), Jasleen Kukreja MD (Verfasst von), Jeffrey A. Golden MD (Verfasst von), Steven R. Hays MD (Verfasst von), Jonathan P. Singer MD (Verfasst von)
• Format: Buch
• Veröffentlicht: SAGE Publishing, 2014-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Belatacept is a novel immunosuppressant that blocks a T-cell costimulation pathway and is approved for use in adult kidney transplant recipients. Its safety and efficacy have not been established after lung transplantation. We present a case of a lung transplant recipient treated with belatacept. A...